These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 15231670)

  • 41. Heregulin regulation of Akt/protein kinase B in breast cancer cells.
    Liu W; Li J; Roth RA
    Biochem Biophys Res Commun; 1999 Aug; 261(3):897-903. PubMed ID: 10441522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells.
    Márquez DC; Pietras RJ
    Oncogene; 2001 Sep; 20(39):5420-30. PubMed ID: 11571639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of growth factor receptor pathways in human breast cancer cells adapted to long-term estrogen deprivation.
    Sabnis GJ; Jelovac D; Long B; Brodie A
    Cancer Res; 2005 May; 65(9):3903-10. PubMed ID: 15867390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer.
    Emberley ED; Niu Y; Curtis L; Troup S; Mandal SK; Myers JN; Gibson SB; Murphy LC; Watson PH
    Cancer Res; 2005 Jul; 65(13):5696-702. PubMed ID: 15994944
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis.
    Tan M; Li P; Klos KS; Lu J; Lan KH; Nagata Y; Fang D; Jing T; Yu D
    Cancer Res; 2005 Mar; 65(5):1858-67. PubMed ID: 15753384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells.
    Wollmann W; Goodman ML; Bhat-Nakshatri P; Kishimoto H; Goulet RJ; Mehrotra S; Morimiya A; Badve S; Nakshatri H
    Carcinogenesis; 2005 May; 26(5):900-7. PubMed ID: 15677629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway.
    Luey BC; May FE
    Mol Cancer; 2016 Jan; 15():8. PubMed ID: 26801096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Esophageal cancer exhibits resistance to a novel IGF-1R inhibitor NVP-AEW541 with maintained RAS-MAPK activity.
    Bao XH; Takaoka M; Hao HF; Wang ZG; Fukazawa T; Yamatsuji T; Sakurama K; Sun DS; Nagasaka T; Fujiwara T; Naomoto Y
    Anticancer Res; 2012 Jul; 32(7):2827-34. PubMed ID: 22753744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors.
    Fuchs M; Hutzler P; Brunner I; Schlegel J; Mages J; Reuning U; Hapke S; Duyster J; Hirohashi S; Genda T; Sakamoto M; Uberall F; Höfler H; Becker KF; Luber B
    Exp Cell Res; 2002 Jun; 276(2):129-41. PubMed ID: 12027444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DOC-2/hDab-2 inhibits ILK activity and induces anoikis in breast cancer cells through an Akt-independent pathway.
    Wang SC; Makino K; Xia W; Kim JS; Im SA; Peng H; Mok SC; Singletary SE; Hung MC
    Oncogene; 2001 Oct; 20(47):6960-4. PubMed ID: 11687976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell cycle regulation of breast cancer cells through estrogen-induced activities of ERK and Akt protein kinases.
    Geffroy N; Guédin A; Dacquet C; Lefebvre P
    Mol Cell Endocrinol; 2005 Jun; 237(1-2):11-23. PubMed ID: 15925090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acquisition of anoikis resistance promotes alterations in the Ras/ERK and PI3K/Akt signaling pathways and matrix remodeling in endothelial cells.
    de Sousa Mesquita AP; de Araújo Lopes S; Pernambuco Filho PCA; Nader HB; Lopes CC
    Apoptosis; 2017 Sep; 22(9):1116-1137. PubMed ID: 28653224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpression and overactivation of Akt in thyroid carcinoma.
    Ringel MD; Hayre N; Saito J; Saunier B; Schuppert F; Burch H; Bernet V; Burman KD; Kohn LD; Saji M
    Cancer Res; 2001 Aug; 61(16):6105-11. PubMed ID: 11507060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of the Akt, cyclooxygenase-2, and matrix metalloproteinase-9 pathways in combination with androgen deprivation therapy: potential therapeutic approaches for prostate cancer.
    Miyamoto H; Altuwaijri S; Cai Y; Messing EM; Chang C
    Mol Carcinog; 2005 Sep; 44(1):1-10. PubMed ID: 16044418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of mitogen-activated protein kinase superfamily proteins unrelated to Ras and AF-1 of estrogen receptor alpha mutation in advanced stage human breast cancer.
    Hori M; Inagawa S; Shimazaki J; Itabashi M; Hori M
    Pathol Res Pract; 2000; 196(12):817-26. PubMed ID: 11156322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ras inhibition amplifies cisplatin sensitivity of human glioblastoma.
    Messina S; Leonetti C; De Gregorio G; Affatigato V; Ragona G; Frati L; Zupi G; Santoni A; Porcellini A
    Biochem Biophys Res Commun; 2004 Jul; 320(2):493-500. PubMed ID: 15219856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. H-RAS V12-induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent.
    Carón RW; Yacoub A; Zhu X; Mitchell C; Han SI; Sasazuki T; Shirasawa S; Hagan MP; Grant S; Dent P
    Mol Cancer Ther; 2005 Feb; 4(2):243-55. PubMed ID: 15713896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. K-Ras and H-Ras activation promote distinct consequences on endometrial cell survival.
    Ninomiya Y; Kato K; Takahashi A; Ueoka Y; Kamikihara T; Arima T; Matsuda T; Kato H; Nishida J; Wake N
    Cancer Res; 2004 Apr; 64(8):2759-65. PubMed ID: 15087391
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of anoikis by Cdc42 and Rac1.
    Cheng TL; Symons M; Jou TS
    Exp Cell Res; 2004 May; 295(2):497-511. PubMed ID: 15093747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activated Notch1 signaling cooperates with papillomavirus oncogenes in transformation and generates resistance to apoptosis on matrix withdrawal through PKB/Akt.
    Rangarajan A; Syal R; Selvarajah S; Chakrabarti O; Sarin A; Krishna S
    Virology; 2001 Jul; 286(1):23-30. PubMed ID: 11448155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.